Status:
UNKNOWN
Wound Healing in Primary TKA
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Total Knee Replacement
Wound Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Wound complications after total knee arthroplasty (TKA) can arise from many patient-specific factors, such as vascular or immune-related medical conditions, obesity, and smoking, among others. The dev...
Eligibility Criteria
Inclusion
- Patients older than 18 years old that will undergo primary TKA with a midline approach
Exclusion
- Previous knee arthroplasty surgeries or midline scars
- TKA secondary to oncologic or traumatic etiologies
- BMI ≥ 40
- uncontrolled diabetes (measured by a Hgb A1c above 8)
- reported allergy to skin adhesive
- immunodeficiencies
- bleeding disorders
- anticoagulation other than ASA
Key Trial Info
Start Date :
August 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT06007599
Start Date
August 16 2023
End Date
October 30 2024
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107